Trial NCT01057277

View at ClinicalTrials.gov 
Org. Study IDs: BrUOG-H&N-229

Last trial update was posted on 2020-02-17

MeSH Interventions

Everolimus

MeSH Conditions

Head and Neck Neoplasms

Other Conditions

Head and Neck Cancer

Stopping Reasons

Pharmaceutical co- re aligned their specialties- no longer will fund H&N ca

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID